YOLFTbeta
26

Dentis Co.,Ltd

261200 · KQ · Healthcare / Medical Instruments & Supplies

2,460.00KRW-135.00 (-5.20%)

Price History

Full chart

Market Stats

Previous Close2,595.00
Open2,585.00
Day Range2,455.00 – 2,665.00
52-Week Range2,125.00 – 5,430.00
Volume48.98K
Market Cap41.26B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.56
50-Day Avg2,577.70
200-Day Avg3,401.13

About

DENTIS CO.,Ltd, together with its subsidiaries, manufactures and sells dental implants and medical devices in Korea and internationally. The company offers implant and implant equipment, digital guide, digital top, kit and tool, and convenience products, such as louis button, MUC, and guide wheel; and allograft bone, xenograft bone, synthetic bone, resorbable membrane, and non-resorbable membrane. It also provides dental unit chair, clinic light, small surgical light, and medium to large surgical light; 3D printer; and transparent orthodontic device. The company offers its products under the Ovis, LUVIS, Zenith, and SERAFIN brands. In addition, it operates a dental e-commerce site, as well as a platform for seminar, content, and community. The company was founded in 2005 and is headquartered in Daegu, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Gi-Bong Shim
  • Employees329
  • HeadquartersSeongseo Industrial Complex, Daegu, South Korea, 42718, Korea
  • Websitehttps://dentis.co.kr

Leadership

  • Mr. Gi-Bong ShimChief Executive Officer

Financials

Income Statement

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Revenue87.09B94.33B114.28B114.25B
Growth (%)-+8.32%+21.15%-0.03%
Cost of Revenue41.60B47.59B61.07B64.73B
Gross Profit45.48B46.74B53.22B49.52B
Gross Margin52.23%49.55%46.57%43.35%
Operating Expense39.90B46.31B53.66B59.93B
Operating Income5.59B428.69M-446.20M-10.41B
Operating Margin6.41%0.45%-0.39%-9.12%
EBITDA7.33B10.73B13.90B-4.54B
EBITDA Margin8.41%11.38%12.16%-3.98%
Net Income1.23B3.83B2.94B-14.20B
Net Income Margin1.41%4.07%2.58%-12.43%
R&D5.03B7.22B6.42B5.78B
R&D as % of Total Revenue5.78%7.66%5.62%5.06%
Interest Expense2.68B3.50B4.72B5.05B
Interest Expense % of Total Revenue3.08%3.71%4.13%4.42%

Balance Sheet

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Assets131.07B187.64B214.25B209.11B
Total Liabilities98.82B130.23B156.32B163.32B
Total Equity29.49B55.46B55.33B46.45B
Cash7.89B17.15B5.04B6.88B
Net Debt46.31B57.98B87.36B95.64B

Cash Flow

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.17B-9.38B-5.36B-9.69B
Capital Expenditure05.64B26.91B16.95B3.94B
Free Cash Flow--471.17M-36.28B-22.30B-13.63B
FCF to OCF--9.11%386.90%416.38%140.70%

Earnings

Report DateJun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------
EPS Actual-32.9917.7518.078.3634.0921.7624.9815.4544.5821.05-6.7416.25-208.94-144.03-600.26247.2931.78-26.75-209.72189.00202.00262.00-611.14274.00109.3196.00-179.09204.00187.00-180.19-76.49-20.30-334.00-39.42-513.65402.13240.09
Surprise-------------------------------------
Timing-------------------------------------

Key Statistics & Ratios

Market Cap41.26B
Enterprise Value139.28B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.37
Price / Book0.71
Revenue (TTM)111.69B
Gross Profit (TTM)48.94B
EBITDA1.58B
Profit Margin1.26%
Operating Margin8.81%
Return on Equity-0.48%
Return on Assets-1.58%
Shares Outstanding15.81M
Shares Float11.24M
Beta0.56
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 4, 20211:5